Investor Link adds Baker Hughes, beat-up biotech

Two oil workers working on drilling rig
Tyler Stableford | Getty Images

Stephanie Link, managing director at TIAA, scooped up shares of two beaten-down names for her model portfolio on Wednesday.

In the hopes of climbing the ranks in CNBC Pro's investing competition, Link took a shot on Baker Hughes and Alexion Pharmaceuticals — two stocks that are both down in 2016, but have recently started to trend higher.

Here are the reasons why she's bullish on these stocks:

Contact Investing


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    Get these newsletters delivered to your inbox, and more info about our products and service. Privacy Policy.